| Secondary |
| Product Used For Unknown Indication |
28.1% |
| Epilepsy |
21.7% |
| Depression |
19.1% |
| Schizophrenia |
3.4% |
| Anxiolytic Therapy |
3.0% |
| Infection |
2.6% |
| Affective Disorder |
2.2% |
| Psychotic Disorder |
2.2% |
| Brain Oedema |
1.9% |
| Gastrostomy |
1.9% |
| Accidental Exposure To Product |
1.5% |
| Antidepressant Therapy |
1.5% |
| Bipolar I Disorder |
1.5% |
| Drug Use For Unknown Indication |
1.5% |
| Mood Altered |
1.5% |
| Sedative Therapy |
1.5% |
| Sleep Disorder |
1.5% |
| Anxiety |
1.1% |
| Asymptomatic Hiv Infection |
1.1% |
| Back Pain |
1.1% |
|
| Hyponatraemia |
8.2% |
| Suicide Attempt |
8.2% |
| Thrombocytopenia |
8.2% |
| Vitamin K Deficiency |
8.2% |
| Pneumonia |
6.1% |
| Polyneuropathy |
6.1% |
| Tracheal Obstruction |
6.1% |
| Weight Increased |
6.1% |
| Withdrawal Syndrome |
6.1% |
| Completed Suicide |
4.1% |
| Confusional State |
4.1% |
| Hallucination |
4.1% |
| Major Depression |
4.1% |
| Pyrexia |
4.1% |
| Troponin Increased |
4.1% |
| Vomiting |
4.1% |
| Accidental Exposure To Product |
2.0% |
| Agitation |
2.0% |
| Drug Exposure During Pregnancy |
2.0% |
| Drug Withdrawal Syndrome Neonatal |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.7% |
| Epilepsy |
15.7% |
| Psychotic Disorder |
14.9% |
| Depression |
5.9% |
| Hypertension |
5.1% |
| Bipolar Disorder |
4.9% |
| Drug Use For Unknown Indication |
4.6% |
| Parkinson's Disease |
3.5% |
| Bronchial Carcinoma |
3.2% |
| Convulsion |
3.0% |
| Hypothyroidism |
2.7% |
| Prophylaxis |
2.4% |
| Schizophrenia |
1.9% |
| Mood Disorder Due To A General Medical Condition |
1.6% |
| Osteoporosis |
1.6% |
| Prophylaxis Of Nausea And Vomiting |
1.6% |
| Sleep Disorder |
1.4% |
| Affective Disorder |
1.1% |
| Dystonia |
1.1% |
| Rheumatoid Arthritis |
1.1% |
|
| Psychotic Disorder |
8.0% |
| Renal Failure Acute |
8.0% |
| Weight Decreased |
8.0% |
| Drug Interaction |
6.0% |
| Hypersomnia |
6.0% |
| Pneumonia |
6.0% |
| Unresponsive To Stimuli |
6.0% |
| Aggression |
4.0% |
| Completed Suicide |
4.0% |
| Depression |
4.0% |
| Ischaemic Stroke |
4.0% |
| Mental Impairment |
4.0% |
| Muscle Contractions Involuntary |
4.0% |
| Pyrexia |
4.0% |
| Speech Disorder |
4.0% |
| Stevens-johnson Syndrome |
4.0% |
| Subdural Haematoma |
4.0% |
| Syncope |
4.0% |
| Toxic Epidermal Necrolysis |
4.0% |
| Vaginal Haemorrhage |
4.0% |
|
| Interacting |
| Product Used For Unknown Indication |
69.6% |
| Immunosuppression |
13.0% |
| Convulsion |
4.3% |
| Delusion |
4.3% |
| Epilepsy |
4.3% |
| Pneumonia Klebsiella |
4.3% |
|
| Neutropenia |
37.5% |
| Tremor |
25.0% |
| Drug Interaction |
12.5% |
| Restlessness |
12.5% |
| Transplant Rejection |
12.5% |
|
